APODANNORDIC PHARMAPACKAGING A/S: Financial statements 2015
CVR: 30541553
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
APODANNORDIC PHARMAPACKAGING A/S (CVR 30541553) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK 15,292,830 and a net result of DKK 8,438,636 compared with DKK 7,620,857 the year before. That is an increase of 8.8% compared with the year before. Equity in the 2015 report amounted to DKK 24,096,494. The solvency ratio was 69.7%.
- Gross Profit
- DKK 15,292,830
- Profit/Loss
- DKK 8,438,636
- Equity
- DKK 24,096,494
- Total Assets
- DKK 34,590,695
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | 15.3M | 8.4M | 24.1M | - |
| 2014 | - | 14.1M | 7.6M | 15.7M | - |
| 2013 | - | 12.6M | 6.5M | 14.5M | - |
| 2012 | - | 6.8M | 2.4M | 8M | - |
Official annual report
How creditworthy is APODANNORDIC PHARMAPACKAGING A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
As of November 30, 2015, Johannes Henricus Adrianus Stols has joined the board of directors of APODANNORDIC PHARMAPACKAGING A/S.
As of November 30, 2015, Gerardus Johannes van Jeveren has left the board of directors of APODANNORDIC PHARMAPACKAGING A/S.
As of October 19, 2015, JS REVISION, STATSAUTORISERET REVISIONSAKTIESELSKAB has been appointed auditor of APODANNORDIC PHARMAPACKAGING A/S.
As of October 19, 2015, EY Godkendt Revisionspartnerselskab has stepped down as auditor of APODANNORDIC PHARMAPACKAGING A/S.
APODANNORDIC PHARMAPACKAGING A/S has published its annual report for 2014. Gross profit came to DKK 14,052,640, and the net result was DKK 7,620,857.
About APODANNORDIC PHARMAPACKAGING A/S
APODANNORDIC PHARMAPACKAGING A/S is a Danish company of the type Aktieselskab based in København S, founded in 2008. The company is registered under the industry Engroshandel med andre råvarer og halvfabrikata. The management consists of Henrik Schøsler Hansen. The board consists of Rafael Padilla Papaceit (chair), Cornelia Neeltje de Jong and Henrik Schøsler Hansen. The company is owned by Fagron BV. The company has 10 employees (2026). In 2025, the company reported a gross profit of DKK 26,020,026 and a net result of DKK 14,541,094 compared with DKK 14,845,402 the year before. Equity in the 2025 report amounted to DKK 44,132,115.
